miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R
Authors:
- 1 January 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 482 (4) , 987-993
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572219)
- Guangdong Natural Science Foundation (2014A030313307)
- Fujian Natural Science Foundation (2016J01450)
This publication has 26 references indexed in Scilit:
- MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinomaMolecular Cancer, 2013
- Current Therapeutic Strategies and Novel Approaches in OsteosarcomaCancers, 2013
- Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcomaBiochemical Pharmacology, 2013
- miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle controlInternational Journal of Oncology, 2012
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinomaJournal of Translational Medicine, 2012
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell CarcinomaClinical Cancer Research, 2009
- International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly personsInternational Journal of Cancer, 2009
- INTERLEUKIN-6: From Basic Science to Medicine—40 Years in ImmunologyAnnual Review of Immunology, 2005
- The functions of animal microRNAsNature, 2004
- MicroRNAsCell, 2004